对我国中性药用玻璃的现状及发展前景初步分析  

Primary Analysis of Present Status and Development Prospect of Domestic Neutral Pharmaceutical Glass

作　　者：鲁旺生[1] 陈静燕[2] 王天栋[1] 

机构地区：[1]秦皇岛玻璃工业研究设计院,秦皇岛市066001 [2]秦皇岛出入境检验检疫局,秦皇岛市066001

出　　处：《玻璃》2015年第8期37-40,共4页Glass

摘　　要：目前我国生产的中性药用玻璃(7.0低硼玻璃)与国际标准的中性药用玻璃(5.0硼硅玻璃)在质量上存在较大差距,而采用国际标准的中性药用玻璃是社会发展的大势所趋,7.0低硼药用玻璃逐步会被国际标准的5.0硼硅药用玻璃替代,中性药用玻璃(5.0硼硅玻璃)发展前景广阔。There is a big gap in quality between domestic made neutral pharmaceutical glass（7.0 lowboron glass）and international standard neutral pharmaceutical glass（5.0 boro-silicate glass）. Adoption of neutral pharmaceutical glass up to international standard is the trend of social development. The 7.0 low-boron pharmaceutical glass will be progressively replaced by the 5.0 boro-silicate glass which has great prospects for development.

关 键 词：中性药用玻璃 7.0低硼玻璃 5.0硼硅玻璃 欧洲药典(EP) 

分 类 号：TQ171[化学工程—玻璃工业]